Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:treprostinil
|
| gptkbp:approvalYear |
2009
|
| gptkbp:ATCCode |
B01AC21
|
| gptkbp:brand |
gptkb:treprostinil
|
| gptkbp:chemicalClass |
prostacyclin analog
|
| gptkbp:form |
inhalation solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tyvaso
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:United_Therapeutics
|
| gptkbp:mechanismOfAction |
prostacyclin analog
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatusUS |
Rx-only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
nausea
dizziness headache cough flushing throat irritation |
| gptkbp:usedFor |
pulmonary arterial hypertension
pulmonary hypertension associated with interstitial lung disease |
| gptkbp:bfsParent |
gptkb:United_Therapeutics
|
| gptkbp:bfsLayer |
7
|